We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Share News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.40
Bid: 467.30
Ask: 467.50
Change: 3.60 (0.78%)
Spread: 0.20 (0.043%)
Open: 464.40
High: 467.50
Low: 463.40
Prev. Close: 463.80
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Aviva First Quarter Sales Rise But Gives Dim 2020 Outlook

Thu, 21st May 2020 08:49

(Alliance News) - Aviva PLC on Wednesday reported a strong start to 2020, with higher new business sales and net premiums, but warned of a performance below expectations for the year as a whole.

For the three months to the end of March, the FTSE 100 insurer said its Life & Savings business reported new business volumes at GBP12.3 billion, a 28% rise from GBP9.6 billion the same period the year before, while the value of new business rose by 18% to GBP311 million.

Meanwhile, for the UK Savings & Retirement segment, net fund flows increased to GBP2.3 billion from GBP1.6 billion through growth in sales across workplace and retail savings.

However, new business sales from the Europe Life dropped by 14% to GBP3.3 billion from GBP3.8 billion, as business volumes fell in Italy even as unit-linked volumes rose in France.

In General Insurance, global net business premiums rose by 3% to GBP2.4 billion from GBP2.3 billion, with 1% growth in the UK to GBP1.0 billion, Canada up 8% to GBP600 million and Europe up 2% to GBP700 billion.

Aviva said its investment portfolio has continued to perform well, with no defaults in its shareholder-backed corporate bond portfolio, and a low loan to value ratio and strong interest cover on commercial mortgages.

Only 5% of investments are in sectors that are the most directly impacted by the pandemic.

Looking ahead, Aviva said the Covid-19 outbreak has provided unprecedented uncertainty, and could adversely impact its results. Already the group has seen new business sales decline in the second quarter to date due to government-enforced restrictions.

For 2020 overall, sales volumes are set to be below expectations.

"We remain committed to achieving our 2022 targets, however, Covid-19 is expected to provide additional challenges to achieving these targets. We remain focused on enhancing customer and operational fundamentals to drive improved returns, better efficiency and cash-flow," the group stated.

Shares in Aviva were up 0.8% at 241.00 pence on Thursday morning in London.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Sep 2023 12:52

IN BRIEF: Watchstone interim loss widens on costs of claim against PwC

Watchstone Group PLC - former insurance software provider originally called Quindell; now cash shell pursuing litigation claims - Pretax loss widens to GBP6.0 million in six months that ended June 30 from GBP2.1 million a year before. Has no revenue, so loss is due to higher administrative expenses. These primarily are legal costs, including GBP4.9 million for Watchstone's claim against PricewaterhouseCoopers LLP. The High Court dismissed Watchstone's claim, and while it seeks permission to appeal, Watchstone must pay PwC's legal costs, as well as its own. Other outstanding claims are against Aviva Canada, part of Aviva PLC, and against UK tax collector HMRC over the recovery of historic VAT. "We remain focussed on realising the group's remaining litigation assets as efficiently as possible and are confident of returning further cash sums to shareholders in due course," Watchstone says.

Read more
13 Sep 2023 17:01

LONDON MARKET CLOSE: FTSE 100 tips into red as UK economy shrinks

(Alliance News) - The FTSE 100 dipped into the red at the close on Wednesday, weighed down by news that the UK economy shrank more than expected in July, just one week before the Bank of England's next interest rate decision.

Read more
13 Sep 2023 11:49

LONDON MARKET MIDDAY: Stocks down as investors wait for US inflation

(Alliance News) - Stock prices in London were lower at midday Wednesday as investors eyed a key US inflation reading later in the day, ahead of the Federal Reserve's interest rate decision next week.

Read more
13 Sep 2023 08:57

LONDON MARKET OPEN: Stocks mixed ahead of key US inflation reading

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of a key US inflation reading, which might impact future interest rate decisions.

Read more
13 Sep 2023 08:48

TOP NEWS: Aviva gets GBP800 million from Singapore Life exit

(Alliance News) - Aviva PLC on Wednesday said it has agreed to sell its quarter ownership of Singapore Life Holdings Pte Ltd to fellow shareholder Sumitomo Life Insurance Co for a total of SGD1.4 billion, about GBP800 million.

Read more
13 Sep 2023 07:01

Aviva sells stake in Singlife, debt instruments to Sumitomo for £0.8bn

(Sharecast News) - UK insurer Aviva on Wednesday said it had agreed to sell its 25.9% stake in Singapore Life Holdings (Singlife), together with two debt instruments, to Sumitomo Life for £800m in cash.

Read more
11 Sep 2023 09:33

LONDON BROKER RATINGS: RBC cuts Melrose Industries to 'sector perform'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
7 Sep 2023 09:45

LONDON BROKER RATINGS: RBC ups ConvaTec; Peel Hunt cuts Harbour Energy

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
5 Sep 2023 14:02

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:58

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 12:38

CORRECTED (OFFICIAL)-Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
5 Sep 2023 06:00

Pent-up private Wegovy demand prompts UK availability concerns

Britain is Novo's fifth market for Wegovy

*

Read more
4 Sep 2023 16:27

Wegovy makes UK weight-loss debut even as Novo struggles with supplies

Novo says Wegovy launch in UK 'controlled and limited'

*

Read more
4 Sep 2023 11:05

British private insurer Aviva will not pay for Novo's weight-loss drug Wegovy

LONDON, Sept 4 (Reuters) - British private insurer Aviva has said it will not pay for treatment with Novo Nordisk's weight-loss drug Wegovy, which launched in the UK on Monday.

Read more
31 Aug 2023 17:02

Miners drag FTSE 100 lower to snap 6-day winning streak

Glencore among top losers on FTSE 100

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.